Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.

Learning during genetic counseling is often below expectations, especially in the context of genetic screening. In this report we describe learning as a result of genetic counseling of 298 pregnant women identified as hemoglobinopathy carriers, 234 with sickle cell trait and 64 with beta-thalassemia trait. Counseling was designed to provide the information needed in a simple, clear, and nondirective manner. A special videotape produced for this purpose provided dramatization and a role model illustrating an appropriate response. After viewing the videotape the counselee had an opportunity to question the counselor and to have any misconceptions corrected. Questionnaires revealed significantly increased knowledge as a result of counseling in each of the three hemoglobinopathy subject areas tested-namely, clinical manifestations, genetics, and prenatal diagnosis. Five factors correlated with higher knowledge scores after counseling-namely, a younger patient age, more years of education, knowledge of having trait before this identification, knowledge of the baby's father having trait before counseling, and having no prior children.     

Glycoproteins. 48. Method for fraction of acetolyzates

Acetolysis, followed by quantitative de-O-acetylation with sodium methylate of the chloroform extract of the acetolyzates and chromatographic fractionation, was applied to the sialoglycopeptide α and asialoglycopeptide β obtained by pronase hydrolysis of ovomucoid. The acetolysis yielded small amounts of monosaccharides and a large proportion of oligosaccharides without transglycosylation. It does not split off the acetamido groups and, on the other hand, the sialosyl and the 2-acetamido-N-(L-aspart-4-oyl)-2-deoxy-β-D-glucopyranosylamine bonds are protected to a high degree. After de-O-acetylation, three fractions are obtained from the chloroform phase in the case of a sialoglycoprotide and two in the case of an asialoglycoprotide by chromatography on ion-exchange resins. The first fraction, not retained, contains neutral oligosaccharides from the median portion of the carbohydrate moieties. The second fraction, present only in the acetolyzates of the sialoglycopeptides and released from the anion-exchange resin, contains sialo-oligosaccharides from the outer part of the carbohydrate moieties. The last fraction, eluted from the cation-exchange resin, contains the glycopeptides and represents the carbohydrate components near the site of attachment to the peptide chain.     

Criteria for Classification of S.L.E

Of 38 patients with systemic lupus erythematosus (S.L.E.) followed in this clinic during the past two years raised levels of anti-DNA antibodies were found in 36. The recently proposed criteria for the classification of S.L.E. were met in 33 of these 36 patients. Three patients with raised DNA antibody titres and some of the features of S.L.E. did not meet the criteria for a classification of S.L.E.     

Cloning of genes for bacterial glycosyltransferases. I. Selection of hybrid plasmids carrying genes for two glucosyltransferases.

A method of identifying plasmids containing genes responsible for synthesis of nucleotide sugar:lipopolysaccharide glycosyltransferases is described. Hybrid ColE1 plasmids containing random fragments of the chromosome of Escherichia coli K12 were introduced into an indicator strain of Salmonella typhimurium which lacks UDP-glucose:lipopolysaccharide glucosyltransferase I due to an rfaG mutation. Plasmids capable of correcting the transferase defect were identified by their ability to convert the bacteriophage sensitivity pattern of the recipient strain from Ffm-sensitive to Ffm-resistant. Analysis of the lipopolysaccharide of the S. typhimurium/ColE1 hybrid strains and assay of cell extracts defined the new enzyme activities. Two plasmids were identified which carried the rfaG+ gene; one of these plasmids also contained genetic information for a second glucosyltransferase, the E. coli glucosyltransferase II, which normally is not present in S. typhimurium.     

Calculation of clinical r.b.e. values for neutrons

A method is described for calculating r.b.e. values for normal tissues at risk in clinical neutron beam therapy. This is based on the assumption that with high l.e.t. radiations the slope of the cell survival curve is steeper, mainly in the initial or low-dose region. This effect is quantified by using two coefficients, one (epsilon) to produce a proportionate increase in the initial slope, and a second (eta) determining the change in the terminal slope (D0) of the survival curve. Analysis of published experimental data shows epsilon to be a variable quantity, different for different tissues; epsilon is larger when the survival curve has a large shoulder or slope ratio (rho). By contrast, eta is relatively constant (for a given beam) and less dependent on the tissue or end-point studied. For low doses, the r.b.e. approaches epsilon, which can be calculated given eta (characteristic of the beam) and rho (characteristic of the relevant tissue) [epsilon = eta + rho(eta - 1)]. This provides a useful approximation to the clinical r.b.e. for specific tissues relative to conventionally fractionated low-l.e.t. photons.     

Improved assay method for activity of thyroid peroxidase-catalysed coupling of iodotyrosine residues of thyroglobulin utilizing h.p.l.c. for analysis of iodothyronines.

The coupling of iodotyrosine residues of thyroglobulin (Tg) catalysed by thyroid peroxidase (TPO) has scarcely been studied with respect to the TPO of abnormal human thyroid glands. The present paper proposes a rapid and convenient assay method applicable for determining the coupling activity of a sample of less than 500 mg from each patient's thyroid. The main characteristics of the method are as follows: (i) mitochondrial/microsomal fractions of thyroid glands were treated with sodium cholate plus trypsin, and the supernatants obtained by ultracentrifugation were directly used for the assay of coupling and peroxidase activity of TPO; (ii) the formation of iodotyrosine residues catalysed by TPO was performed by using chemically iodinated Graves'-disease Tg containing 41 iodine atoms per molecule and with a high iodotyrosine and a low iodothyronine content; (iii) newly synthesized iodothyronine residues (thyroxine, 3,5,3'-tri-iodothyronine, and 3,3',5'-tri-iodothyronine) were analysed by h.p.l.c. after hydrolysis of Tg with proteinases and extraction of iodothyronines with ethyl acetate.